Get started
Work

Supplementary Figure 3 from Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

Year: 2023
Type: supplementary-materials
Abstract: PD-L1 expression levels on mouse bladders containing MB49 tumors and on normal mouse bladders.
DOI: 10.1158/2326-6066.22538513.v1
Authors: Amanda J. Vandeveer, Jonathan K. Fallon, Robert Tighe, Helen Sabzevari, Jeffrey Schlom, John W. Greiner
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362539935
Cites:
Cited by:
Related to: 10